Update on the Treatment of Autonomic Disorders.

Area of Science:

• Neurology
• Autonomic Nervous System Research
• Clinical Therapeutics

Background:

• Autonomic disorders, or dysautonomia, disrupt bodily homeostasis, leading to diverse symptoms.
• Causes of dysautonomia are varied, including neurodegeneration, autoimmunity, and medication side effects.
• While disease-modifying treatments are limited for common causes, symptomatic management is crucial.

Purpose of the Study:

• To review established and recent therapeutic strategies for managing dysautonomia.
• To provide a clinical schema for approaching the management of autonomic disorders.
• To highlight novel neuromodulatory devices and pharmacological agents.

Main Methods:

• Review of established and emerging therapeutic strategies for dysautonomia.
• Focus on common clinical issues and a stepwise management approach.
• Integration of non-pharmacological, pharmacological, and neuromodulatory treatments.

Main Results:

• Neuromodulatory devices show promise for orthostatic hypotension, urinary dysfunction, sexual dysfunction, constipation, and gastroparesis.
• Newer medications like droxidopa, β-3-adrenergic agonists, prucalopride, elobixibat, and linaclotide offer improved efficacy and tolerability.
• A stepwise approach integrating multiple strategies aids in managing common dysautonomia symptoms.

Conclusions:

• Effective management of dysautonomia relies on a combination of therapeutic strategies.
• Emerging neuromodulatory and pharmacological options expand treatment possibilities.
• A structured clinical approach is essential for optimizing patient care in autonomic disorders.